Additionally, LMI’s advanced protocols are designed to optimize stem cell distribution, ensuring therapeutic benefits to both the lungs and other target tissues, maximizing the regenerative potential. At LMI, we mitigate some of the first-pass effect using several proprietary strategies: • Oxygen supplementation during infusion improves oxygenation and reduces lung inflammation, helping the cells circulate more effectively. • Slower administration of stem cells minimize the risk of lung entrapment, allowing more cells to bypass the lungs and reach target areas. • Nutraceuticals as Natural Vasodilators: We also include natural neutraceutical vasodilators in our IV protocols, which help improve blood flow and reduce lung entrapment, further enhancing cell circulation. • Exosome therapy is also employed, as exosomes are smaller and bypass lung entrapment, providing a powerful addition to whole cells. These approaches significantly improve the efficacy and safety of our stem cell treatments. How does oxygen supplementation help during MSC administration? Oxygen supplementation improves the lung's microcirculation, reduces local hypoxia (low oxygen levels), and optimizes the pulmonary environment for MSC passage. This can:
• Decrease MSC trapping in the lungs.
• Enhance MSC viability and function by preventing hypoxia-induced stress.
• Support better distribution of MSCs to systemic target tissues. Are Stem Cell and Exosome Therapies Safe for Patients with Active Cancer? MSC and exosome therapies are not recommended for patients with active cancer due to the potential risk of stimulating tumor growth. These therapies are only considered safe after a patient has been in remission for at least five years and is under strict medical supervision. Why Does LMI Use AI MRI Screening Before Administering MSC and Exosome Therapies? At LMI, we prioritize safety by using AI-powered MRI screening to detect any undiagnosed cancer or any of over 500 conditions before treatment. This high-precision screening ensures that MSC and exosome therapies are appropriate for each patient. What if I Tried Stem Cell Treatments in the Past and Did Not Notice Any Benefits? While stem cell therapies have reported an average of 80% success rate (defined as an improvement in the condition), individual results depend on several factors, including the specific condition being treated and the quality and type of the stem cells used. At LMI, we ensure that you receive the right type of stem cell for your needs, and we follow stringent protocols for for harvesting, culturing, and processing to maintain at least 98% cell viability
© 2024 Longevity Medical Institute. All rights reserved.
8
Made with FlippingBook flipbook maker